Profile
International Journal of Laboratory Medicine & Research Volume 1 (2015), Article ID 1:IJLMR-107, 3 pages
http://dx.doi.org/10.15344/2455-4006/2015/107
Commentary
Apolipoprotein E-knockout Mice as a Lifestyle-related Disease Model of Atherosclerosis and Non-alcoholic Fatty Liver Disease

Masa-Aki Shibata1*, E. Shibata2, S. Fujioka1 and M. Harada-Shiba2

1Laboratory of Anatomy & Histopathology, Graduate School of Heath Sciences, Osaka Health Science University, Japan
2Department of Molecular Innovation in Lipidology, National Cerebral & Cardiovascular Center Research Institute, Japan
Prof. Masa-Aki Shibata, Laboratory of Anatomy & Histopathology Graduate School of Heath Sciences, Osaka Health Science University, 1-9-27, Temma, Kita-ku, Osaka, 530-0043, Japan, Tel: +81-6-7506- 9046; Fax: 81-6-6352-5995; E-mail: masaaki.shibata@ohsu.ac.jp
12 October 2015; 14 October 2015; 16 October 2015
Shibata MA, Shibata E, Fujioka S, Harada-Shiba M (2015) Apolipoprotein E-knockout Mice as a Lifestyle-related Disease Model of Atherosclerosis and Non-alcoholic Fatty Liver Disease. Int J Lab Med Res 1: 107. doi: http://dx.doi.org/10.15344/2455-4006/2015/107
This work was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor and Welfare (H23- seisakutansaku-ippan-004. A member of this research: Dr. M.A. Shibata. The research representative: Dr. M. Harada-Shiba).

References

  1. World Health Organization. The top 10 causes of death in the world, 2000 and 2012. Fact sheet No 310; updated May 2014. View
  2. Ministry of Health, Labor and Welfare in Japan Annual Report 2012. The top 10 causes of death in Japan , 2012. View
  3. Review Team: LaBrecque DR, Abbas Z, Anania F, Ferenci P, et al. (2014) World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J Clin Gastroenterol 48: 467-473. View
  4. Lavine JE, Schwimmer JB (2004) Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis 8: 549-558, viii-ix. View
  5. Targher G (2007) Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. Diabet Med 24: 1-6. View
  6. Cohen JC, Horton JD, Hobbs HH (2011) Human fatty liver disease: old questions and new insights. Science 332: 1519-1523. View
  7. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N (1992) Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A 89: 4471-4475. View
  8. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, et al. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71: 343-353. View
  9. Coleman R, Hayek T, Keidar S, Aviram M (2006) A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. Acta Histochem 108: 415-424. View
  10. Meyrelles SS, Peotta VA, Pereira TM, Vasquez EC (2011) Endothelial dysfunction in the apolipoprotein E-deficient mouse: insights into the influence of diet, gender and aging. Lipids Health Dis 10: 211. View
  11. Stachowicz A, Olszanecki R, Suski M, Wiśniewska A, Totoń-Żurańska J, et al. (2014) Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice. J Am Heart Assoc 3: e001329. View
  12. Shibata MA, Shibata E, Fujioka S, Harada-Shiba M (2015) Atherosclerosis in apolipoprotein E-knockout mice as a model of human disease. Austin J Cardiovasc Dis Atherosclerosis 2: 1011.